• Fri, March 6, 2020

by: WOPRAI

Michael Scialla Maintained (APA) at Strong Buy with Decreased Target to $37 on, Mar 6th, 2020

by: WOPRAI

Michael Rollins Upgraded (AMT) to Strong Buy and Held Target at $280 on, Mar 6th, 2020

by: WOPRAI

Kevin Fitzsimmons Upgraded (CARE) to Strong Buy and Decreased Target to $19 on, Mar 6th, 2020

by: WOPRAI

Neena Bitritto-Garg Initiated (ALEC) at Strong Buy and Held Target at $40 on, Mar 6th, 2020

by: WOPRAI

Ashish Sabadra Maintained (ADT) at Hold with Decreased Target to $7 on, Mar 6th, 2020

by: WOPRAI

Jeriel Ong Maintained (AAPL) at Hold with Decreased Target to $74 on, Mar 6th, 2020

by: WOPRAI

Wamsi Mohan Reiterated (AAPL) at Strong Buy and Held Target at $350 on, Mar 6th, 2020

by: WOPRAI

Keay Nakae Upgraded (ABUS) to Strong Buy and Increased Target to $5 on, Mar 6th, 2020

by: WOPRAI

Neena Bitritto-Garg Initiated (ACAD) at Strong Buy and Held Target at $69 on, Mar 6th, 2020

by: WOPRAI

Matt Miksic Maintained (ABT) at Buy with Decreased Target to $94 on, Mar 6th, 2020

by: WOPRAI

Hans Chung Maintained (VIPS) at Buy with Increased Target to $21 on, Mar 6th, 2020

by: WOPRAI

Alicia Yap Upgraded (VIPS) to Strong Buy and Increased Target to $20 on, Mar 6th, 2020

by: WOPRAI

Jialong Shi Upgraded (VIPS) to Strong Buy and Held Target at $20 on, Mar 6th, 2020

by: WOPRAI

Michael Gaugler Upgraded (UTL) to Strong Buy and Held Target at $62 on, Mar 6th, 2020

by: WOPRAI

Ianjit Bhatti Upgraded (AMD) to Buy and Increased Target to $60 on, Mar 6th, 2020

by: WOPRAI

Christian Schwab Upgraded (AMD) to Strong Buy on, Mar 6th, 2020

by: WOPRAI

Ross Seymore Maintained (AMD) at Hold with Increased Target to $50 on, Mar 6th, 2020

by: WOPRAI

Matt Miksic Maintained (BAX) at Buy with Increased Target to $98 on, Mar 6th, 2020

by: WOPRAI

Alastair Syme Maintained (XOM) at Hold with Decreased Target to $52 on, Mar 6th, 2020

by: WOPRAI

Doug Leggate Maintained (XOM) at Strong Buy with Decreased Target to $98 on, Mar 6th, 2020

by: WOPRAI

Matt Miksic Maintained (BSX) at Buy with Decreased Target to $46 on, Mar 6th, 2020

by: WOPRAI

Paul Lejuez Upgraded (BURL) to Strong Buy and Increased Target to $260 on, Mar 6th, 2020

by: WOPRAI

Mark Altschwager Maintained (BURL) at Buy with Increased Target to $255 on, Mar 6th, 2020

by: WOPRAI

Paul Trussell Reiterated (BURL) at Strong Buy with Decreased Target to $245 on, Mar 6th, 2020

by: WOPRAI

Jennifer Demba Downgraded (CFR) to Hold and Decreased Target to $80 on, Mar 6th, 2020

by: WOPRAI

Jailendra Singh Maintained (TDOC) at Hold with Increased Target to $137 on, Mar 6th, 2020

by: WOPRAI

Keith Horowitz Maintained (WFC) at Hold with Decreased Target to $45 on, Mar 6th, 2020

by: WOPRAI

Michael Baker Upgraded (ULTA) to Hold and Held Target at $230 on, Mar 6th, 2020

by: WOPRAI

Mayank Tandon Maintained (SQ) at Strong Buy with Decreased Target to $95 on, Mar 6th, 2020

by: WOPRAI

Josh Nichols Maintained (SMSI) at Strong Buy with Increased Target to $72 on, Mar 6th, 2020

by: WOPRAI

Craig Ellis Maintained (SMTC) at Strong Buy with Decreased Target to $55 on, Mar 6th, 2020

by: WOPRAI

Alethia Young Maintained (AUPH) at Buy with Increased Target to $32 on, Mar 6th, 2020

by: WOPRAI

Swayampakula Ramakanth Reiterated (ATEC) at Strong Buy with Increased Target to $9.5 on, Mar 6th, 2020

by: WOPRAI

Jason Bazinet Initiated (TRVG) at Strong Buy and Held Target at $11 on, Mar 6th, 2020

by: WOPRAI

Jason Bazinet Initiated (TRIP) at Hold and Held Target at $25 on, Mar 6th, 2020

by: WOPRAI

Christopher Horvers Upgraded (BJ) to Buy and Increased Target to $29 on, Mar 6th, 2020

by: WOPRAI

Michael Baker Maintained (BJ) at Strong Buy with Decreased Target to $27 on, Mar 6th, 2020

by: WOPRAI

Simeon Gutman Maintained (BJ) at Hold with Decreased Target to $26 on, Mar 6th, 2020

by: WOPRAI

Judah Frommer Maintained (BJ) at Buy with Increased Target to $26 on, Mar 6th, 2020

by: WOPRAI

Jason Bazinet Initiated (BKNG) at Strong Buy on, Mar 6th, 2020

by: WOPRAI

John Staszak Downgraded (BKNG) to Hold on, Mar 6th, 2020

by: WOPRAI

Andrew Fein Reiterated (SYRS) at Hold with Decreased Target to $80 on, Mar 6th, 2020

by: WOPRAI

Joshua Pokrzywinski Maintained (SWK) at Buy with Decreased Target to $168 on, Mar 6th, 2020

by: WOPRAI

Matt Miksic Maintained (SYK) at Buy with Decreased Target to $247 on, Mar 6th, 2020

  • Sun, March 8, 2020

by: WOPRAI

Daniel Ives Maintained (AAPL) at Buy and Held Target at $400 on, Mar 8th, 2020

  • Mon, March 9, 2020

by: WOPRAI

Todd Stender Maintained (SUI) at Hold with Increased Target to $158 on, Mar 9th, 2020

by: WOPRAI

Benjamin Nolan Upgraded (STNG) to Strong Buy and Held Target at $30 on, Mar 9th, 2020

by: WOPRAI

Nicolay Dyvik Downgraded (STNG) to Hold on, Mar 9th, 2020

Andrew Fein Reiterated (SYRS) at Hold with Decreased Target to $80 on, Mar 6th, 2020

Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Hold with Decreased Target from $100 to $80 on, Mar 6th, 2020.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Nierengarten of "Wedbush" Downgraded from Buy to Hold and Held Target at $90 on, Friday, January 17th, 2020

Like: 👍